Wileycanada:: You Have Encountered An Error Wiley Canada, vascular dementia Current Concepts by I. Prohovnik (Editor), J.Wade (Editor), S. Knezevic (Editor), T. Tatemichi (Editor), T. Erkinjuntti http://www.wileycanada.com/cda/product/0,,047195294X,00.html
Extractions: By Keyword By Title By Author By ISBN By ISSN We're Sorry, You Encountered the Following Error: Product page could not be found with isbn 047195294X We apologize for any inconvenience. If you are looking for a specific product, you can enter information in the search box at the top right-hand corner of this page. If you still encounter problems, please contact our webmaster
VASCULAR DEMENTIA vascular dementia, the second most common cause of dementia, is associated withproblems in the circulation of blood to the brain. vascular dementia. http://www.mydr.com.au/default.asp?article=2521
Extractions: John C. Morris, M.D., associate professor of neurology and assistant professor of pathology, has received a five-year $1.5 million grant to study the dementia that can follow stroke. The grant comes from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. Stroke is a major contributor to dementia, second only to Alzheimer's disease. "But few studies have studied it separately from Alzheimer's disease, so there is a great deal of confusion," said Morris, co-director of Washington University's Alzheimer's Disease Research Center. Stroke occurs when a blood vessel becomes blocked or bursts, preventing oxygen and nutrients from reaching a region of brain tissue. Death of such tissue can hamper cognitive function, leading to dementia. The researchers will determine whether the clinical symptoms of vascular dementia are the same as those that typify Alzheimer's disease. They also will identify the areas of the brain in which damage can lead to dementia and study whether dementia arises suddenly after stroke or develops gradually before or after. The study will involve 270 men and women at risk for stroke because of high blood pressure or constricted carotid arteries. The subjects will come from studies already under way at the School of Medicine.
Vascular Dementia vascular dementia (VaD). Dementia is a term to describe a loss of mental abilities. About1520% of people with dementia have a diagnosis of vascular dementia. http://www.uwcm.ac.uk/study/medicine/geriatric_medicine/ageing_brain/cardiff_mem
AAV - Help Sheets : Vascular Dementia Help Sheets, vascular dementia. For more information click here. vascular dementiais the second most common cause of dementia after Alzheimers disease. http://www.alzvic.asn.au/ad10.htm
Extractions: Vascular dementia is the second most common cause of dementia after Alzheimers disease. This Help Sheet describes Vascular dementia, its causes, diagnosis and progression. What is Vascular dementia? Vascular dementia is the broad term for dementia associated with problems of the circulation of blood to the brain. Are there different types of Vascular dementia? There are a number of different types of Vascular dementia. Two of the most common are: Multi-infarct dementia This is probably the most common form of Vascular dementia. Multi-infarct dementia is caused by a number of small strokes, called mini-strokes or Transient Ischaemic Attacks (TIA). The strokes cause damage to the cortex of the brain - the area associated with learning, memory and language. A person with Multi-infarct dementia is likely to have better insight into their condition in the early stages than people with Alzheimers disease, and parts of their personality may remain relatively intact for longer. Symptoms may include severe depression, mood swings and epilepsy. Binswangers disease (also known as Subcortical vascular dementia)
Vascular Dementia From Eyewitness News Healthbeat vascular dementia By Pat Mastors Jan 7, 2003, 537pm.More than four years ago, 82year-old Phoebe Demello suffered a stroke. http://www.wpri.com/artman/publish/7229.shtml
VASCULAR DEMENTIA vascular dementia A state of diminished cognition thatis the results from repeated cerebral strokes. http://www.medhelp.org/glossary2/new/GLS_4755.HTM
Intact Brain Serotonin System In Vascular Dementia Hansson G, Alafuzoff I, Winblad B, Marcusson J. Intact brain serotoninsystem in vascular dementia. Dementia 19967196200. Abstract. http://www.uku.fi/neuro/ab9647.htm
Extractions: U K U N E U R O S C I E N C E P U B L I C A T I O N S Hansson G, Alafuzoff I, Winblad B, Marcusson J. Intact brain serotonin system in vascular dementia. Dementia 1996:7:196-200 Abstract Pre- and postsynaptic elements of the 5-hydroxytryptamine (5-HT, serotonin) system were studied in a control group and in patients with vascular dementia (VAD). The 5-HT uptake site was used as a presynaptic marker for 5-HT terminals and 5-HT1A and 5HT2 receptors were used as postsynaptic markers. The binding sites were quantified with radioligand binding techniques, where the radioligands used were [3H]paroxetine, [3H]8-OH-DPAT and [3H]ketanserin, respectively. The presynaptic uptake site was studied in frontal and temporal cortices and caudate nucleus. 5-HT1A and 5-HT2 receptors were studied only in frontal and temporal cortices. There were no differences between control and VAD groups in any of the regions investigated with respect to the number of binding sites (Bmax) and binding affinity (Kd). This indicates that both pre- and postsynaptic parts of the 5-HT system are intact in these brain areas in VAD.
Extractions: U K U N E U R O S C I E N C E P U B L I C A T I O N S Du A, Schuff N, Laakso MP, Zhu XP, Jagust W, Yaffe K, Kramer JH, Miller B, Reed B, Norman D, Chui HC, Weiner MW. Effects of subcortical ischemic vascular dementia and Alzheimers disease on entorhinal cortex and hippocampus. Neurology 2002;58:1635-1641 Abstract Objective: To determine the effects of subcortical ischemic vascular dementia (SIVD) and AD on entorhinal cortex (ERC) and hippocampus. Methods: Thirty-eight cognitively normal subjects, 18 patients with SIVD, and 22 patients with AD were included. Volumes of ERC and hippocampus were manually measured based on MRI. Global cerebral changes of cortical gray matter, subcortical gray matter, white matter, sulcal CSF, ventricular CSF (vCSF), and white matter signal hyperintensities (WMSH) were assessed. Results: Patients with SIVD had 21.7% (p < 0.01) smaller ERC and 18.2% (p < 0.01) smaller hippocampi than cognitively normal subjects and 24.4% (p < 0.01) larger ERC and 11.1% (p < 0.05) larger hippocampi than patients with AD. In addition, patients with SIVD had less cortical gray matter and white matter and more vCSF and WMSH (all p
The Clinical Diagnosis Of Vascular Dementia, The ICD-10 Criteria The Clinical Diagnosis of vascular dementia, The ICD10 Criteria for VascularDementia, The Neurochemistry of vascular dementia, The use of lornoxicam http://www.nycomed.ru/library.jsp?letter=48&sortby=title
Pathogenesis Of Vascular Dementia The Possible Role Of Pathogenesis of vascular dementia The Possible Role of Hypertension, Pathology andPathophysiology of Cerebrovascular dementia Pure Subgroups of Obstructive http://www.nycomed.ru/library.jsp?letter=44&sortby=title
Vascular Dementia The summary for this Chinese (Traditional) page contains characters that cannot be correctly displayed in this language/character set. http://www.cgmh.org.tw/intr/intr4/c8370/ynchen/academic/clinical neuropsychology
Extractions: In a study published in the October 3 2002 issue of Stroke: Journal of the American Heart Association ( http://stroke.ahajournals.org/ ), researchers from Queen's University in Belfast, Ireland have found that having moderately high homocysteine is associated with three times the risk of Alzheimer's disease, and five times the risk of stroke and vascular dementia compared to those with healthier levels of the toxic amino acid. The researchers studied 83 patients with Alzheimer's disease, 78 with vascular dementia, 64 stroke patients and 71 healthy volunteers, all in their seventies. Data was collected on diet, cholesterol, smoking history and blood pressure, and fasting plasma homocysteine levels were taken. The subjects were also tested for variation in the gene methylenetetrahydrofolate, which can affect folate metabolism. The B vitamin folate has been shown to reduce homocysteine. An increase in plasma homocysteine was found in the Alzheimer's, vascular dementia and stroke groups compared with the healthy controls, which remained significant after adjustment for other factors. The findings were not related to mutations in the methylenetetrahydrofolate gene. Lead author and lecturer in geriatric medicine at Queen's University in Belfast, Stephen P. McIlroy, PhD, stated, ?Since B vitamins and foods fortified with folate can reduce homocysteine levels, this study suggests that B vitamin supplementation may be appropriate for most adults. It warrants a large placebo-controlled study of folate, and vitamins B6 and B12 in people at risk from dementia and stroke."
Extractions: Subcortical Vascular Dementia: Survey of Treatment Patterns and Research Considerations Frank J. Molnar, Malcolm Man-Son-Hing, Phil St. John, Chris Brymer, Kenneth Rockwood and Vladimir Hachinski Abstract: Background: Since few studies have examined the effectiveness of therapies for subcortical vascular dementia, treatment guidelines are not available. Current patterns in the treatment of such dementias have not been studied. Objective: To determine the practice patterns of Canadian specialists for the treatment of subcortical vascular dementia, and to survey their opinions regarding issues which are important in the design of a randomized controlled trial (RCT) in this field. Design: National survey of all specialists certified in Neurology or Geriatric Medicine. Results: Conclusions: Specialist physician practice patterns vary significantly for the treatment of patients with subcortical vascular dementia. Most physicians believe that an RCT testing the efficacy of aspirin in this condition is required. However, before such a trial can be conducted, many methodological difficulties need to be addressed.
Pfeiffer :: You Have Encountered An Error Pfeiffer, vascular dementia Current Concepts by I. Prohovnik (Editor), J. Wade (Editor),S. Knezevic (Editor), T. Tatemichi (Editor), T. Erkinjuntti (Editor). http://www.pfeiffer.com/cda/product/0,,047195294X,00.html
Extractions: MM_preloadImages( "/legacy/include/images/sb_nav_home_over.gif", "/legacy/include/images/sb_nav_browsetitles_on.gif", "/legacy/include/images/sb_nav_offers_on.gif", "/legacy/include/images/sb_nav_join_on.gif", "/legacy/include/images/sb_nav_aboutpfeiffer_on.gif", "/legacy/include/images/sb_nav_about_wiley_on.gif", "/legacy/include/images/sb_nav_extras_on.gif" ); By Keyword By Title By Author By ISBN By ISSN Shopping Cart My Account Help Contact Us We're Sorry, You Encountered the Following Error: Product page could not be found with isbn 047195294X We apologize for any inconvenience. If you are looking for a specific product, you can enter information in the search box at the top right-hand corner of this page. If you still encounter problems, please contact our webmaster
ICD 10 Criteria For Vascular Dementia ICD 10 Criteria for vascular dementia. G1. Evidence of dementia ofspecified level of severity. G2. Unequal distribution of deficits http://www.mayo.edu/geriatrics-rst/VascDem.html
Dementia: Vascular Dementia - Conceptual Click on the Title to get full details . Test. HOME. ADEAR.HHARResearch. NLM Other Links. Retirement Research Foundation. http://www.wrescu-nac.org/Dementia/VDConce.html
Minimise The Impact Of Vascular Dementia Minimise the Impact of vascular dementia by Controlling Risk Factorsfrom Drugs Therapy Perspectives. Introduction. Dementias among http://www.medscape.com/viewarticle/406298